Get the latest tech news

Formation Bio raises $372M to boost drug development with AI


Formation Bio has raised $372 million for its AI-powered tech to speed up drug discovery processes. OpenAI CEO Sam Altman is an investor.

A hacker claims to be selling an extensive database associated with an Indian government portal meant for blue-collar workforce emigrating from the country. Formation Bio, a startup focused on applying AI to drug discovery with backing from OpenAI CEO Sam Altman, has raised over a quarter-billion dollars to support its ambitious product roadmap.… In May, when OpenAI first demoed an eerily realistic, nearly real-time “advanced voice mode” for its AI-powered chatbot platform ChatGPT, the company said that the feature would roll out to…

Get the Android app

Or read this on TechCrunch

Read more on:

Photo of drug development

drug development

Photo of Formation Bio

Formation Bio

Related news:

News photo

How A.I. Is Revolutionizing Drug Development

News photo

McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI

News photo

McKesson, Merck back Atropos Health’s $30M round to accelerate drug development with AI